ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,552, issued on July 15, was assigned to Juris Germanas (Ellicott City, Md.).

"Hydroxyquinoline compounds and methods of use as pigment modifying agents" was invented by Juris Germanas (Ellicot City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments disclosed provide pharmaceutical formulations for tyrosinase inhibitors, as well as methods for dermatological treatment of hyperpigmentation disorders. The pharmaceutical formulations comprise tyrosinase inhibitors, each containing a structural core of 8-hydroxyquinoline, and are applied in a suitable carrier as topical treatments for hyperpigmentation. In some embodiments at least one addit...